AI assistant
Sending…
BIODESIX INC — Director's Dealing 2025
Jul 2, 2025
34472_dirs_2025-07-02_f3c4de04-d2f8-489a-aa76-07dfbc4e2e45.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2025-07-01
Reporting Person: MASSARANY HANY (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-01 | Common Stock | M | 26368 | — | Acquired | 310135 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-07-01 | Restricted Stock Units | $ | M | 26368 | Disposed | Common Stock (26368) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 53364 | Indirect |
Footnotes
F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2: Mr. Massarany is a trustee of the Massarany Family Trust and may be deemed to have beneficial ownership of these securities, to the extent of any indirect pecuniary interest in his distributive shares therein.
F3: These fully vested RSUs settled on July 1, 2025, and had no expiration date.
More from BIODESIX INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23